coproporphyrin i has been researched along with aminolevulinic acid in 4 studies
*Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. [MeSH]
*Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arrol, S; Cutler, MG | 1 |
| Amantea, A; Anti, M; D'Alessandro Gandolfo, L; de Vitis, I; Fedeli, G; Griso, D; Rapaccini, GL; Topi, GC | 1 |
| Doss, MO; Egeler, E; Gross, U; Jacob, K | 1 |
| Chen, JW; Wang, Q; Ye, LX; Zhao, HH; Zhou, YK | 1 |
1 trial(s) available for coproporphyrin i and aminolevulinic acid
| Article | Year |
|---|---|
Investigations on the formation of urinary coproporphyrin isomers I-IV in 5-aminolevulinic acid dehydratase deficiency porphyria, acute lead intoxication and after oral 5-aminolevulinic acid loading.
Topics: Administration, Oral; Aminolevulinic Acid; Coproporphyrins; Humans; Isomerism; Lead Poisoning; Male; Porphobilinogen Synthase; Porphyria, Acute Intermittent | 1999 |
3 other study(ies) available for coproporphyrin i and aminolevulinic acid
| Article | Year |
|---|---|
Pharmacological effects of haem biosynthetic intermediates in isolated intestinal preparations.
Topics: Aminolevulinic Acid; Animals; Colon; Coproporphyrins; Female; Glycine; Heme; Hemin; In Vitro Techniques; Intestinal Mucosa; Intestines; Jejunum; Male; Muscle Contraction; Porphobilinogen; Protoporphyrins; Rabbits; Succinates | 1987 |
Porphyrins in Rotor's syndrome: a study on an Italian family.
Topics: Adult; Aminolevulinic Acid; Coproporphyrins; Female; Humans; Jaundice; Liver; Male; Porphobilinogen; Porphyrins; Syndrome | 1986 |
Benchmark dose approach for low-level lead induced haematogenesis inhibition and associations of childhood intelligences with ALAD activity and ALA levels.
Topics: Aminolevulinic Acid; Benchmarking; Biomarkers; Child; Coproporphyrins; Dose-Response Relationship, Drug; Environmental Pollutants; Female; Hematopoiesis; Humans; Intelligence; Lead; Male; Porphobilinogen Synthase; Protoporphyrins | 2011 |